Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

16 Aug 2012 11:29

RNS Number : 1678K
Oryx International Growth Fund Ld
16 August 2012
 

ORYX INTERNATIONAL GROWTH FUND LIMITED

 INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 30 JUNE 2012

 Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

 This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 This interim management statement relates to the period from 1 April 2012 to 30 June 2012, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 Manager's Review

During the period under review, the FTSE Small Cap TR (£) Index returned -4.24% and the FTSE All-Share TR Index (£) returned -2.63%. Against this, the Fund's net asset value decreased by 4.5% to 292p per share.

 The Manager anticipates that a number of the holdings within the Company's portfolio will benefit from corporate activity during the next twelve months.

 Material Transactions

Since 1 April 2012, the Company has purchased for cancellation the following shares:

 24 April 2012 a total of 379,653 ordinary shares at a gross price of £2.10 per share.

Material Events

There were no material events during the quarter ended 30 June 2012.

 Report and Accounts

On 15 June 2012, the Company posted its Annual Report and Accounts for the year ended 31 March 2012, to Shareholders.

Financial Highlights

 

 

30 June 2012 

31 March 2012 

31 December 2011 

30 September 2011 

30 June 2011 

 

 

 

 

 

 

NAV

£2.93

£3.03

£2.79

£2.69

£2.96

 

 

 

 

 

 

US Dollar / Sterling Exchange Rate

 

1.5685

 

1.5978

 

1.5541

 

1.5579

 

1.6055

 

 

 

 

 

 

 

 

Twenty Largest Equity Investments at 30 June 2012

 

% Net Assets

Cvs Group Plc

7.85

Bioquell Plc

6.84

Gleeson (M.J.) Group Plc

6.67

Guinness Peat Group Plc

6.36

Orthoproducts Ltd

4.99

Augean Plc

4.96

Journey Group Plc

4.29

Eckoh Plc

4.28

Quarto Group Inc

4.26

Catalyst Media Group Plc

4.14

Assetco Plc

3.80

Innovation Group Plc

3.76

Sinclair Is Pharma Plc

3.23

Rpc Group Plc

2.75

Nastor Inv Ltd Zero Redeem Prefer Shares

2.61

Mecom Group Plc

2.42

Bionostics Holdings Ltd

2.40

Celsis Ag

2.09

Bavaria Industriekapital Ag

2.09

Sinav Limited

1.99

81.78

 

 

The financial information for the quarter ended 30 June 2012 contained within this Interim Management Statement has not been audited.

 

By order of the Board

 

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUCPRUPPGUQ
Date   Source Headline
3rd Jul 20172:20 pmRNSTotal Voting Rights
3rd Jul 201710:47 amRNSTotal Voting Rights
26th Jun 201710:23 amRNSNet Asset Value(s)
15th Jun 201711:23 amRNSHolding(s) in Company
12th Jun 20178:16 amRNSTransaction in Own Shares
2nd Jun 201710:37 amRNSNet Asset Value(s)
23rd May 20173:31 pmRNSHolding(s) in Company
22nd May 20179:06 amRNSHolding(s) in Company
15th May 20178:40 amRNSTR-1: Notification of Major Interest in Shares
4th May 20174:09 pmRNSTotal Voting Rights
28th Apr 20179:45 amRNSNet Asset Value(s)
25th Apr 20173:33 pmRNSHolding(s) in Company
20th Apr 20173:07 pmRNSTR-1: Notification of major interest in shares
10th Apr 20177:00 amRNSHolding(s) in Company
7th Apr 20177:00 amRNSTransaction in Own Shares
6th Apr 201711:11 amRNSTotal Voting Rights
4th Apr 20173:52 pmRNSForm 8.3 - Frenkel Topping Group plc
3rd Apr 201711:49 amRNSTransaction in Own Shares
31st Mar 20177:00 amRNSDirectorate Change
28th Mar 20174:16 pmRNSHolding(s) in Company
27th Mar 20179:26 amRNSTransaction in Own Shares
23rd Mar 20177:00 amRNSTransaction in Own Shares
22nd Mar 20173:55 pmRNSNet Asset Value(s)
10th Mar 20172:45 pmRNSsignificant shareholding
1st Mar 20178:39 amRNSHolding(s) in Company
27th Feb 201712:02 pmRNSNet Asset Value(s)
21st Feb 20179:56 amRNSNet Asset Value(s)
7th Feb 20173:27 pmRNSTR-1: Notification of Major Interest in Shares
1st Feb 20174:16 pmRNSTotal Voting Rights
27th Jan 20177:00 amRNSTransaction in Own Shares
19th Jan 201712:54 pmRNSHolding(s) in Company
16th Jan 20177:00 amRNSHolding(s) in Company
3rd Jan 201711:34 amRNSNet Asset Value(s)
30th Dec 20167:00 amRNSSubmission Details for TR1 Forms
22nd Dec 20168:59 amRNSHolding(s) in Company
15th Dec 20164:20 pmRNSHolding(s) in Company
13th Dec 20167:00 amRNSHalf-year Report
23rd Nov 20161:41 pmRNSNet Asset Value(s)
18th Nov 20163:28 pmRNSHolding(s) in Company
26th Oct 201610:08 amRNSHolding(s) in Company
26th Oct 20169:28 amRNSHolding(s) in Company
24th Oct 201610:56 amRNSNet Asset Value(s)
5th Oct 20163:30 pmRNSTR-1: Notification Of Major Interest In Shares
23rd Sep 20165:22 pmRNSNet Asset Value(s)
1st Sep 20164:45 pmRNSHolding(s) in Company
31st Aug 20163:33 pmRNSNet Asset Value(s)
26th Aug 20162:48 pmRNSResult of AGM
25th Aug 20162:25 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
22nd Aug 20169:48 amRNSTransaction in Own Shares
19th Aug 201611:41 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.